Watts Water Technologies Inc WTS
No buyback or stock pay figures in its 10-K data yet
XBRL, 10-KNew shares against shares bought back
Dilution: new shares, stock pay and buybacks · S-3 and 424B, 3 years; 10-K
Shares offered
Since Nov 17, 2023: 1 shelf registration.
- May 9, 2024 Shelf registration: shares and other securities, amount not fixed S-3ASR
Every offering filing“Under this shelf registration process, we or any selling security holders may from time to time sell any combination of the securities described in this prospectus in one or more offerings.”
S-3ASR, May 9, 2024
Paid in stock and bought back
No stock pay or buyback lines in the 10-K XBRL.
Where the cash came from and where it went
FY2025, from the cash flow statement in the 10-K, added up
The same cash, step by step
Came from
| Operating cash flow | $402.0M |
Went to
| Capital spending | $45.7M |
| Acquisitions | $257.1M |
| Buybacks | $16.0M |
| Added to cash | $18.6M |
| Other, net investments bought and sold, other financing and investing lines, and exchange rates |
$64.6M |
Each number is a line of the cash flow statement as the company tagged it. "Other, net" is what those lines do not cover (investments bought and sold, other financing and investing lines, and exchange rates); Tickdelta does not estimate it.
Where the operating cash went, year by year
FY2016 to FY2025 · cash flow statements, 10-K XBRL
| Fiscal year | Operating cash | Capital spending | Acquisitions | Buybacks | Debt repaid |
|---|---|---|---|---|---|
| Dec 31, 2025 | $402.0M | $45.7M | $257.1M | $16.0M | - |
| Dec 31, 2024 | $361.1M | $35.3M | $96.3M | $17.0M | $100.0M |
| Dec 31, 2023 | $310.8M | $29.7M | $313.4M | $16.0M | $90.0M |
| Dec 31, 2022 | $224.0M | $28.1M | - | $69.4M | $80.0M |
| Dec 31, 2021 | $180.8M | $26.7M | $9.1M | $16.0M | $95.0M |
| Dec 31, 2020 | $228.8M | $43.8M | $15.2M | $28.9M | $517.5M |
| Dec 31, 2019 | $194.0M | $29.2M | $42.7M | $19.5M | $127.0M |
| Dec 31, 2018 | $169.4M | $35.9M | $1.7M | $26.0M | $194.5M |
| Dec 31, 2017 | $155.9M | $29.4M | - | $18.2M | $178.0M |
| Dec 31, 2016 | $138.1M | $36.0M | $88.0M | $26.8M | $614.4M |
| Added up | $2.4B | $339.8M 14% of operating cash | $823.5M 35% of operating cash | $253.8M 11% of operating cash | $2.0B 84% of operating cash |
Each bar is one fiscal year; its colours add up to what the cash flow statement says the company spent on each line, and the line across it is that year's operating cash flow. Spending above the line was paid from new debt, shares sold or cash on hand. A bar part links to the 10-K it comes from. A line the company did not report is left out, not estimated, so the shares are of operating cash only and can add up to more or less than 100%. Debt repaid is the gross amount, so refinanced debt is counted each time it is repaid. A reading aid, not a grade: Tickdelta does not say whether a split was good. Banks and insurers are left out.
Buybacks, dividends and share count
Year by year · XBRL, each 10-K
No buyback or share count data in the 10-K XBRL.
Dividend per share, year by year
Dividends · declared per share, each 10-K; cash paid, cash flow statement
Declared since the 10-K: Sep 27, 2026 $0.63Jun 28, 2026 $0.63Mar 29, 2026 $0.52
| Fiscal year to | Per share | Against year before | Cash paid out |
|---|---|---|---|
| Dec 31, 2025 | $1.99 | ▲+20.6% | - |
| Dec 31, 2024 | $1.65 | ▲+19.6% | - |
| Dec 31, 2023 | $1.38 | ▲+19.0% | - |
| Dec 31, 2022 | $1.16 | ▲+14.9% | - |
| Dec 31, 2021 | $1.01 | ▲+9.8% | - |
| Dec 31, 2020 | $0.92 | ▲+2.2% | - |
| Dec 31, 2019 | $0.90 | ▲+9.8% | - |
| Dec 31, 2018 | $0.82 | ▲+9.3% | - |
Dividend per share as the company tagged it (CommonStockDividendsPerShareCashPaid), from the latest 10-K that reports each year, so a stock split is already in it. A change is left blank when the year before is missing or the jump is more than five times.
Buybacks month by month, and what is left to buy
Share buybacks · 10-Q, Part II Item 2, latest 4 quarters
“On July 31, 2023, we announced that our Board of Directors had authorized a repurchase program of up to $150 million of our Class A common stock, to be purchased from time to time on the open market or in privately negotiated transactions, which has no expiration date.”
10-Q, Part II Item 2
The monthly table could not be read from the text of these 10-Qs: open the latest 10-Q, Part II Item 2.
What it paid for each share it bought back
Price paid · 10-K, statement of shareholders' equity
What WTS paid on average for each share it bought back, each fiscal year: dollars spent divided by shares bought, both from the 10-K.
| Fiscal year to | Shares bought | Spent | Average price |
|---|---|---|---|
| Dec 31, 2025 | 67K | $16.0M | $240.53 |
| Dec 31, 2024 | 85K | $17.0M | $198.98 |
| Dec 31, 2023 | 92K | $16.0M | $174.63 |
| Dec 31, 2022 | 494K | $69.4M | $140.56 |
| Dec 31, 2021 | 110K | $16.0M | $145.46 |
| Dec 31, 2020 | 332K | $28.9M | $87.17 |
| Dec 31, 2014 | 670K | $39.6M | $59.10 |
| Dec 31, 2013 | 454K | $23.0M | $50.66 |
Shares and dollars from the statement of shareholders' equity (the cash flow line also counts shares withheld for taxes, so it is not used). Share counts filed before a stock split are put on today's count. A year where the 10-K does not tag both numbers is left out.
What the 10-Ks show for each CEO's years
Each CEO's years · the CEO of each fiscal year as named in the proxy's pay versus performance table
Robert J. Pagano, Jr.
- Operating cash flow
- $402.0M
- Capital spending
- $45.7M
- Acquisitions
- $257.1M
- Buybacks
- $16.0M
- Stock-based pay
- $21.2M
- Diluted shares since FY2024
- +0.0%
- Revenue since FY2024
- +8%
- Debt since FY2024
- +$700K
- CEO pay (reported)
- $10.4M
Sources
The cash flow statement, dividends per share and diluted share count in each 10-K's XBRL; Part II Item 2 of each 10-Q for monthly buybacks; offering prospectuses (S-3, 424B) for new shares; Form D data sets for private raises.
Also
CEO pay: what the CEO was paid over the same years.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/WTS/export.csv") into a cell.